ARCHIVES

An “insurgency” targets randomized trials, demands access to investigational drugs.

This article is from The Cancer Letter archive.

Vol. 31 No. 31 | August 5, 2005

Download PDF Visit The Full Archive

Related Articles

Pathology Review Confirms Reserpine As Carcinogen

March 14, 1980

Brief: President Expected To Propose 4.7% Increase In NIH Budget; Bernard Fisher Wins Award

January 14, 1994

Study Finds High-Risk Women Reluctant To Take Tamoxifen

December 25, 2009

South Carolina Politicos Join Hollings Oncology Center Section

October 30, 1992

In Brief: NCI, EPA Award contract For Farmers study To Iowa, North Carolina; NIAID’s Hoth to Resign

January 29, 1993

NCAB Asks Government To Take Steps Aimed at Reducing Health Hazards From Cigarettes

December 21, 1973